Literature DB >> 7648768

Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans.

B Plaud1, J H Proost, J M Wierda, J Barre, B Debaene, C Meistelman.   

Abstract

The pharmacokinetic-pharmacodynamic relationship of rocuronium at the laryngeal adductor muscles and the adductor pollicis was determined in eight patients during general anesthesia. Rocuronium was administered as an infusion at a rate of 100 micrograms.kg-1.min-1 over 5 minutes. The half-life of transport between plasma and biophase (effect compartment) was significantly shorter at the adductor laryngeal muscles (2.7 +/- 0.6 minutes, mean +/- SD) than at the adductor pollicis (4.4 +/- 1.5 minutes, p = 0.003). The concentration in the effect compartment producing 50% of the maximum effect was significantly greater at the adductor laryngeal muscles (1424 +/- 148 micrograms.L-1) than at the adductor pollicis (823 +/- 157 micrograms.L-1, p = 0.0001). The shorter onset of neuromuscular blockade at the laryngeal muscles than at the adductor pollicis may be explained by a faster transfer rate at the laryngeal adductor muscles neuromuscular junction than at the adductor pollicis neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648768     DOI: 10.1016/0009-9236(95)90196-5

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  The relationship between rate of administration of an intubating dose of rocuronium and time to 50% and 90% block at the adductor pollicis muscle.

Authors:  A De Haes; D J Eleveld; J M Wierda
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

3.  The relationship between the target effective site concentration of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients.

Authors:  Xiaochong Fan; Minyu Ma; Zhisong Li; Shengkai Gong; Wei Zhang; Yuanyuan Wen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 4.  Rapacuronium bromide: a review of its use in anaesthetic practice.

Authors:  S V Onrust; R H Foster
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 5.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Onset of rocuronium-induced neuromuscular block evaluated subjectively and accerelomyographically at the masseter muscle.

Authors:  Osamu Kitajima; Takahiro Suzuki; Naoko Fukano; Shigeru Saeki; Setsuro Ogawa; Yoshikazu Noda
Journal:  J Anesth       Date:  2011-04-12       Impact factor: 2.078

7.  Duration of succinylcholine and vecuronium blockade but not potency correlates with the ratio of endplate size to fibre size in seven muscles in the goat.

Authors:  C Ibebunjo; C B Srikant; F Donati
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

8.  Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.

Authors:  Kenichi Masui; Sayaka Ishigaki; Atsuko Tomita; Hiroshi Otake
Journal:  J Anesth       Date:  2018-08-11       Impact factor: 2.078

Review 9.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

10.  Electromyographic activation reveals cortical and sub-cortical dissociation during emergence from general anesthesia.

Authors:  Darren F Hight; Logan J Voss; Paul S García; Jamie W Sleigh
Journal:  J Clin Monit Comput       Date:  2016-07-21       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.